Delivery Order SPE2DB22D1202-SPE2DB24FVDX0

Award Date 6/17/24
Potential Completion Date 6/18/24
Potential Value $3.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Vyvanse 40mg capsules. The $5,172.12 firm fixed-price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) the company holds with DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,414.32 firm fixed-price delivery order is for the supply of 100 units of the 30 mg capsule form of the drug Vyvanse. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by Amerisourcebergen with the DLA, which serves as the primary vehicle for providing a comprehensive range of...
This federal contract award, valued at $7,871.56, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4559838389 - Vyvanse 40 mg capsules in 100-count packages. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,276.40 firm fixed-price delivery order is for the supply of 100 units of 50 mg Vyvanse capsules. The contract has an ultimate completion date of January 16, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,116.93 firm fixed-price delivery order is for the supply of Vyvanse 40 mg capsules, with an ultimate completion date of October 29, 2024. The award is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,819.25 firm fixed-price delivery order covers the supply of Vyvanse 40 mg capsules for the DLA. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,273.76 firm-fixed-price delivery order is for the supply of 100 units of Vyvanse 10 mg capsules. The contract has an ultimate completion date of February 25, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,524.90 firm fixed-price delivery order is for the supply of 4,564,337,332 units of Vyvanse 20 mg capsules. The contract has an ultimate completion date of April 22, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,566,359,320 units of Vyvanse 50 mg capsules. The contract has a ceiling value of $4,006.50 and is a firm-fixed price delivery order, with a period of performance through November 7, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,778.38 firm fixed-price delivery order is for the supply of 40 mg capsules of the prescription drug Vyvanse, with an ultimate completion date of October 29, 2024. The contract is not designated with any set-aside requirements, indicating open competition. AmerisourceBergen holds a significant $999,999,999...
  • SPE2DB22D1202
    Indefinite Delivery Contract
  • SPE2DB22D1202-SPE2DB24FVDX0
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and supplier to the U.S. government. The $3,930.50 firm-fixed-price delivery order is for the supply of Vyvanse 40mg capsules, a prescription medication.

The award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under this single-award IDC, Amerisourcebergen provides a wide range of pharmaceutical products and medical supplies to support the Department of Defense's healthcare programs and facilities worldwide. The contract does not have a set-aside designation.

In addition to the DLA IDC, Amerisourcebergen also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.

Generated 9/16/24, 10:38 AM